We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Details Regulatory Arrangements for No-Deal Brexit
MHRA Details Regulatory Arrangements for No-Deal Brexit
The UK’s Medicines and Healthcare products Regulatory Agency released new details of how it plans to continue drug regulatory operations if there is no Brexit deal by March 29 — including new fees to cover its added regulatory burden.